Dietary advanced glycation end products consumption as a direct modulator of insulin sensitivity in overweight humans: A study protocol for a double-blind, randomized, two period cross-over trial

JMIR Research Protocols

Volumn 4, Issue 3, 2015, Pages

  De Courten, Barbora ^a   de Courten, Maximilian P J ^b   Schalkwijk, Casper G ^c   Walker, Karen Z ^a   Forbes, Josephine ^d  

^a MONASH UNIVERSITY   (Australia)

^b VICTORIA UNIVERSITY   (Australia)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Advanced glycation; Diet; Inflammation, carboxymethyllysine; Insulin secretion; Insulin sensitivity; Type 2 diabetes

Indexed keywords

EID: 84973177007     PISSN: None     EISSN: 19290748     Source Type: Journal    
DOI: 10.2196/resprot.4552     Document Type: Article

References (35)

1. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, et al. Origins and evolution of the Western diet: Health implications for the 21st century. Am J Clin Nutr 2005 Feb; 81(2):341-354 [FREE Full text] [Medline: 15699220]
2. Henle T. Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foods. Amino Acids 2005 Dec; 29(4):313-322. [doi: 10.1007/s00726-005-0200-2] [Medline: 15997413]
3. Li S, Liu Y, Sigmon VK, McCort A, Ren J. High-fat diet enhances visceral advanced glycation end products, nuclear O-Glc-Nac modification, p38 mitogen-activated protein kinase activation and apoptosis. Diabetes Obes Metab 2005 Jul; 7(4):448-454. [doi: 10.1111/j.1463-1326.2004.00387.x] [Medline: 15955132]
4. Nangaku M, Izuhara Y, Usuda N, Inagi R, Shibata T, Sugiyama S, et al. In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy. Nephrol Dial Transplant 2005 Dec; 20(12):2661-2669 [FREE Full text] [doi: 10.1093/ndt/gfi096] [Medline: 16188903]
5. Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 2010 Jun; 110(6):911-16.e12 [FREE Full text] [doi: 10.1016/j.jada.2010.03.018] [Medline: 20497781]
6. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004 May; 27(5):1047-1053. [Medline: 15111519]
7. Hofmann SM, Dong H, Li Z, Cai W, Altomonte J, Thung SN, et al. Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes 2002 Jul; 51(7):2082-2089 [FREE Full text] [Medline: 12086936]
8. Sandu O, Song K, Cai W, Zheng F, Uribarri J, Vlassara H. Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. Diabetes 2005 Aug; 54(8):2314-2319 [FREE Full text] [Medline: 16046296]
9. Harcourt BE, Sourris KC, Coughlan MT, Walker KZ, Dougherty SL, Andrikopoulos S, et al. Targeted reduction of advanced glycation improves renal function in obesity. Kidney Int 2011 Jul; 80(2):190-198. [doi: 10.1038/ki.2011.57] [Medline: 21412218]
10. Cai W, He JC, Zhu L, Lu C, Vlassara H. Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor. Proc Natl Acad Sci USA 2006 Sep 12; 103(37):13801-13806 [FREE Full text] [doi: 10.1073/pnas.0600362103] [Medline: 16954185]
11. Uribarri J, Cai W, Ramdas M, Goodman S, Pyzik R, Chen X, et al. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: Potential role of AGER1 and SIRT1. Diabetes Care 2011 Jul; 34(7):1610-1616 [FREE Full text] [doi: 10.2337/dc11-0091] [Medline: 21709297]
12. Mark AB, Poulsen MW, Andersen S, Andersen JM, Bak MJ, Ritz C, et al. Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women. Diabetes Care 2014; 37(1):88-95. [doi: 10.2337/dc13-0842] [Medline: 23959566]
13. Coughlan MT, Yap FY, Tong DC, Andrikopoulos S, Gasser A, Thallas-Bonke V, et al. Advanced glycation end products are direct modulators of β-cell function. Diabetes 2011 Oct; 60(10):2523-2532 [FREE Full text] [doi: 10.2337/db10-1033] [Medline: 21911745]
14. Zhao Z, Zhao C, Zhang XH, Zheng F, Cai W, Vlassara H, et al. Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis. Endocrinology 2009 Jun; 150(6):2569-2576 [FREE Full text] [doi: 10.1210/en.2008-1342] [Medline: 19246537]
15. Kaneto H, Fujii J, Myint T, Miyazawa N, Islam KN, Kawasaki Y, et al. Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem J 1996 Dec 15; 320 ( Pt 3):855-863. [Medline: 9003372]
16. Forbes JM, Söderlund J, Yap FY, Knip M, Andrikopoulos S, Ilonen J, et al. Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia 2011 May; 54(5):1032-1042. [doi: 10.1007/s00125-011-2058-z] [Medline: 21298413]
17. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 2003 Jan; 88(1):157-161. [doi: 10.1210/jc.2002-020978] [Medline: 12519845]
18. Bischof MG, Heinze G, Vierhapper H. Vitamin D status and its relation to age and body mass index. Horm Res 2006; 66(5):211-215. [doi: 10.1159/000094932] [Medline: 16900001]
19. Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 2002 Oct; 51(10):2968-2974 [FREE Full text] [Medline: 12351435]
20. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998 Jul; 15(7):539-553. [doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO; 2-S] [Medline: 9686693]
21. Craig C, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003 Aug; 35(8):1381-1395. [doi: 10.1249/01.MSS.0000078924.61453.FB] [Medline: 12900694]
22. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957 May; 226(1):497-509 [FREE Full text] [Medline: 13428781]
23. Goldberg T, Cai W, Peppa M, Dardaine V, Baliga BS, Uribarri J, et al. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 2004 Aug; 104(8):1287-1291. [doi: 10.1016/j.jada.2004.05.214] [Medline: 15281050]
24. Hanssen NM, Engelen L, Ferreira I, Scheijen JL, Huijberts MS, van Greevenbroek MM, et al. Plasma levels of advanced glycation endproducts N-(carboxymethyl)lysine, N-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: The Hoorn and CODAM studies. J Clin Endocrinol Metab 2013 Aug; 98(8):E1369-E1373. [doi: 10.1210/jc.2013-1068] [Medline: 23780372]
25. Foerster A, Henle T. Glycation in food and metabolic transit of dietary AGEs (advanced glycation end-products): Studies on the urinary excretion of pyrraline. Biochem Soc Trans 2003 Dec; 31(Pt 6):1383-1385. [doi: 10.1042/bst0311383] [Medline: 14641068]
26. Penfold SA, Coughlan MT, Patel SK, Srivastava PM, Sourris KC, Steer D, et al. Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy. Kidney Int 2010 Aug; 78(3):287-295. [doi: 10.1038/ki.2010.134] [Medline: 20463655]
27. Diabetes Prevention Program (DPP) Research Group, Hamman RF, Horton E, Barrett-Connor E, Bray GA, Christophi CA, et al. Factors affecting the decline in incidence of diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS). Diabetes 2015 Mar; 64(3):989-998. [doi: 10.2337/db14-0333] [Medline: 25277389]
28. Shaw J. Diabetes: The silent pandemic and its impact on Australia.: Diabetes Australia; 2012. URL:http://www. diabetesaustralia.com.au/Documents/DA/What%27s%20New/12.03.14%20Diabetes%20management%20booklet%20FINAL. pdf [accessed 2015-07-04] [WebCite Cache ID 6ZlPXwePD]
29. Brown MA, Storlien LH, Brown IL, Higgins JA. Cooking attenuates the ability of high-amylose meals to reduce plasma insulin concentrations in rats. Br J Nutr 2003 Oct; 90(4):823-827. [Medline: 13129452]
30. Lioger D, Fardet A, Foassert P, Davicco M, Mardon J, Gaillard-Martinie B, et al. Influence of sourdough prefermentation, of steam cooking suppression and of decreased sucrose content during wheat flakes processing on the plasma glucose and insulin responses and satiety of healthy subjects. J Am Coll Nutr 2009 Feb; 28(1):30-36. [Medline: 19571157]
31. Vaaler S, Hanssen KF, Aagenaes O. The effect of cooking upon the blood glucose response to ingested carrots and potatoes. Diabetes Care 1984; 7(3):221-223. [Medline: 6734389]
32. Birlouez-Aragon I, Saavedra G, Tessier FJ, Galinier A, Ait-Ameur L, Lacoste F, et al. A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am J Clin Nutr 2010 May; 91(5):1220-1226 [FREE Full text] [doi: 10.3945/ajcn.2009.28737] [Medline: 20335546]
33. Jia X, Wu L. Accumulation of endogenous methylglyoxal impaired insulin signaling in adipose tissue of fructose-fed rats. Mol Cell Biochem 2007 Dec; 306(1-2):133-139. [doi: 10.1007/s11010-007-9563-x] [Medline: 17660951]
34. Riboulet-Chavey A, Pierron A, Durand I, Murdaca J, Giudicelli J, Van OE. Methylglyoxal impairs the insulin signaling pathways independently of the formation of intracellular reactive oxygen species. Diabetes 2006 May; 55(5):1289-1299 [FREE Full text] [Medline: 16644685]
35. Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001 Dec; 50(12):2792-2808 [FREE Full text] [Medline: 11723063]